-
Product Insights
New![]()
DP World Solar PV Farm
DP World Solar PV Farm is a solar PV project located in Dubai, United Arab Emirates. The project is owned and developed by Phanes Group. The project came online in 2017. Empower your strategies with our DP World Solar PV Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
New![]()
Jiangsu Rudong ODWF (Intertidal) DP – Extension
Jiangsu Rudong ODWF (Intertidal) DP - Extension is an offshore wind project located in East China Sea, China. The project is owned and developed by China Longyuan Power Group Corp Ltd. The project came online in 2013. Empower your strategies with our Jiangsu Rudong ODWF (Intertidal) DP - Extension report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DP-303c in Gastric Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.DP-303c in Gastric Cancer Drug Details:DP-303c is under development for the treatment of HER2 low expressing...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DP-303c in Peritoneal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.DP-303c in Peritoneal Cancer Drug Details:DP-303c is under development for the treatment of HER2 low expressing...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SON-DP in Metastatic Breast Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.SON-DP in Metastatic Breast Cancer Drug Details: Proteins are under development for the treatment of metastatic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SON-DP in Metastatic Pancreatic Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.SON-DP in Metastatic Pancreatic Cancer Drug Details: Proteins are under development for the treatment of metastatic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SON-DP in Metastatic Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.SON-DP in Metastatic Colorectal Cancer Drug Details: Proteins are under development for the treatment of metastatic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SON-DP in Metastatic Ovarian Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.SON-DP in Metastatic Ovarian Cancer Drug Details: Proteins are under development for the treatment of metastatic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DP-303c in Epithelial Ovarian Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.DP-303c in Epithelial Ovarian Cancer Drug Details:DP-303c is under development for the treatment of HER2 low...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DP-303c in Fallopian Tube Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.DP-303c in Fallopian Tube Cancer Drug Details:DP-303c is under development for the treatment of HER2 low...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.